Objectives: To identify risk factors for poor outcome one year post-mild traumatic brain injury (mTBI).
Design: This study was a prospective observational study using consecutive adult hospital admissions with mTBI.
Subjects: A total of 869 consecutive mTBI patients were enrolled in this study.
Objectives: Pain is a known complication in persons with hemophilia (PWH) as a result of muscle and joint bleeding. Little is known regarding national Hemophilia Treatment Center (HTC) practice patterns related to pain management. The aim of this study was to: 1) Describe pain management practice patterns of HTC providers, 2) Identify gaps and areas of alignment with the CDC pain guidelines, and 3) Address educational opportunities for pain management.
View Article and Find Full Text PDFObjective: To determine the prevalence of employment status (ES) or full-time study after traumatic brain injury (TBI) in a representative population and its predictive factors.
Design: Prospective cohort study.
Setting: Regional Major Trauma Centre.
: To assess the impact of social deprivation on Traumatic Brain Injury (TBI) global outcome.: The study was a prospective observational study conducted using consecutive admissions with TBI.: 1322 consecutive adult patients with TBI were recruited into the study between 2010 and 2015.
View Article and Find Full Text PDFCurr Med Res Opin
February 2019
Objective: The term cerebral microbleed (CMB) refers to lesions documented as unexpected findings during computed tomography or magnetic resonance imaging examination of the brain. Initially, a CMB was thought to represent hemosiderin-laden macrophages marking an area of a tiny hemorrhage. Recently, histopathologic studies have shown that the structure of a CMB can be variable.
View Article and Find Full Text PDFPurpose: Previous retrospective claims database analyses reported increased prevalence and earlier onset of cardiovascular comorbidities in patients with versus without hemophilia A. A comprehensive chart review was designed to further investigate previous findings.
Methods: This retrospective chart review study was conducted at Henry Ford Health System (Detroit, MI, USA).
In patients with severe hemophilia A, recurrent bleeding into joints results in increased morbidity and reduced quality of life. Prophylaxis using replacement factor products, especially when initiated early, has established benefits in terms of reducing joint bleeds and preserving joint function. Poor adherence to prophylactic regimens is a common cause for breakthrough bleeds and resultant arthropathy.
View Article and Find Full Text PDFObjectives. Prophylaxis regimens for severe hemophilia A allowing more flexible dosing while maintaining efficacy may improve adherence and decrease the cost of prophylaxis. Here, we compared the clinical effectiveness of once- or twice-weekly versus ≥3-times-weekly prophylaxis with sucrose-formulated recombinant factor VIII (rFVIII-FS) in a "real-world" practice setting.
View Article and Find Full Text PDF